not tagged
not tagged
[]
at #esmo22 showed long term results of gim2 study (ph3 trial evaluating dose-dense ct vs standard interval ct): after &gt;15yrs f-u, dose dense ct is associated with better dfs ( 9%) and os ( 7%). benefit is regardless hr status (7% in hr+, 13% in hr-) 
MD, Medical Oncologist????•Research Fellow at @JulesBordet Institute in Brussels???? Great interest in #BreastCancer and #ImmunoOncology